KORU Medical Systems KRMD Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five)
Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five) at other companies
Other financials
Where this comes from
Reported directly by KORU Medical Systems in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive.
The official record: KORU Medical Systems’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about KORU Medical Systems's finite-lived intangible assets - expected amortization expense (year five).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is KORU Medical Systems's finite-lived intangible assets - expected amortization expense (year five)?
- KORU Medical Systems (KRMD) reported finite-lived intangible assets - expected amortization expense (year five) of $360.01K in Q4 2025.
- How has KORU Medical Systems's finite-lived intangible assets - expected amortization expense (year five) changed year-over-year?
- KORU Medical Systems's finite-lived intangible assets - expected amortization expense (year five) decreased by 11.5% year-over-year, from $406.66K to $360.01K.
- What is the long-term trend for KORU Medical Systems's finite-lived intangible assets - expected amortization expense (year five)?
- Over 5 years (2020 to 2025), KORU Medical Systems's finite-lived intangible assets - expected amortization expense (year five) has grown at a -8.1% compound annual growth rate (CAGR), from $548.44K to $360.01K.
- What does finite-lived intangible assets - expected amortization expense (year five) mean?
- This represents the projected non-cash expense associated with the amortization of finite-lived intangible assets specifically for the fifth year following the current reporting period. It provides insight into the long-term impact of past acquisitions or capitalized intangible investments on future earnings. This helps investors model the long-term expense profile of the company's asset base.